Portfolio (Quarterly)
Guide ↗
ANDERA PARTNERS
· CIK 0001757283| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KMTS | KESTRA MED TECHNOLOGIES LTD | Healthcare | 2,695,192.0 | $53.7M | 30.36% | +155K | +6.1% | $19.93 | +10.7% |
| 2 | EVMN | EVOMMUNE INC | Healthcare | 1,897,362.0 | $43.6M | 24.66% | — | — | $22.99 | +0.8% |
| 3 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 1,591,917.0 | $43.1M | 24.38% | — | — | $27.09 | +12.8% |
| 4 | AGMB | AGOMAB THERAPEUTICS NV | Healthcare | 1,538,702.0 | $16.1M | 9.12% | NEW | — | $10.49 | +8.4% |
| 5 | IVA | INVENTIVA SA | Healthcare | 1,818,181.0 | $10.1M | 5.70% | — | — | $5.55 | -8.1% |
| 6 | ABVX | ABIVAX SA | Healthcare | 78,125.0 | $8.7M | 4.92% | — | — | $111.35 | +12.8% |
| 7 | — | NYXOAH S A | — | 522,057.0 | $1.5M | 0.86% | NEW | — | $2.92 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%